Sponsors, CROs and academic research teams choosing an eCOA platform for a regulated clinical trial.
Scope Electronic clinical outcome assessment (eCOA) platforms that capture patient-reported (ePRO), clinician-reported, observer-reported and performance outcomes in regulated clinical trials, as a sponsor, CRO or academic research team would shortlist them.
These notes describe the products in the eCOA guide.
Medable
Best for
Sponsors and CROs that want a no-code eCOA build tool with eConsent and televisits on one platform
What to consider
Medable pairs a large library (400+ validated instruments, 120+ locales) with Study Studio, a no-code builder its site says takes studies live in 4 to 6 weeks. It publishes Part 11, Annex 11, HIPAA and GDPR compliance but no regulatory approval counts or prices.
Large sponsors and CROs that already run Rave EDC and want eCOA in the same platform
What to consider
Medidata eCOA lists 2,500+ COAs, 200+ languages and dialects and 1,600+ studies, and data flows straight into Rave EDC. Study builders can configure it in Medidata Designer, with an average study start of 8 weeks. Prices are not published.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
Medable vs Medidata eCOA (eCOA): category feature evidence and sources. Products are not ranked.
Category feature
Medable
Medidata eCOA
Validated instrument library and licensingFeature definitions
Supported
A library of outcome-assessment instruments is documented.
Extended support
A validated or instrument-author-approved library plus managed instrument licensing are documented.
Medable
Supported
400+ pre-built, validated instruments in a reusable library with AI-assisted instrument generation; licensing services are not described on the pages checked.
A validated library is documented; licensing services are not described.
Medidata eCOA
Extended support
2,500+ COAs and a global instrument library for reusing builds and translations; Medidata also offers a validated instrument license management service.
A reusable instrument library is paired with a validated instrument license-management service.
Regulatory compliance and track recordFeature definitions
Supported
Relevant trial or security controls are stated.
Extended support
Relevant trial controls plus a public ISO/SOC certificate or audit report are documented; a certification claim or logo alone is insufficient.
Medable
Supported
States compliance with 21 CFR Part 11, Annex 11, HIPAA, GDPR and ICH GCP and says its eCOA data can support primary endpoints in pivotal studies; deployed in nearly 400 trials, with no approval counts published.
Medidata says its AI functionality supports 80% of 2025 FDA novel drug approvals (company-wide platform claim, not eCOA alone); position statements on Part 11, Annex 11 and ICH E6 are published.
A no-code builder and launch timing are documented; study-team self-service is not explicit.
Medidata eCOA
Extended support
Medidata Designer lets study builders configure questionnaires with drag-and-drop templates; average study start 8 weeks versus a 12-week industry standard.
A monthly device-provisioning model is described; platform prices are not published.
Medidata eCOA
Supported
No prices published; Medidata's public Patient Cloud service descriptions set out contract terms, such as devices provisioned on a rental basis, caps on fee adjustments and early-termination fees.